TP53 and cancer: The mutations can be particularly severe in Li-Fraumeni syndrome, in which a mutated TP53 gene dramatically increases the risk of cancers like osteosarcoma, leukemia, breast cancer, brain tumors, and adrenal tumors (Vaddavalli and Schumacher, 2022).